Wei Lin
Senior Health Economist at Genentech
- Role
- Senior Health Economist at Genentech
- Location
- South San Francisco, CA, US
- LinkedIn followers
- 500 followers
Experience
Senior Health Economist
Dec 2024 — Present
Oncology - Hematology | Evidence for Access (E4A)| Policy Evidence and Access Strategy- Lead Venclexta AML and MDS indications HEOR strategy development and execution- Represent E4A in the cross-functional MDS launch team and work closely with external co-commercialization partners
Education
University of Minnesota
Master of Science (M.S.), Health Services Research, Policy & Administration
2010 — 2012
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Doctor of Philosophy (Ph.D.), Pharmaceutical Economics and Policy
2012 — 2017
National Taiwan University
Bachelor of Science (BS), Pharmacy
2004 — 2008
Skills
- Statistics
- Public Health
- Sas
- Stata
- Informatics
- Pharmaceutical Industry
- Pharmacoeconomics
- Epidemiology
- Clinical Research
- Systematic Reviews
- Pediatrics
- Outcomes Research
- Biostatistics
- Pharmacoepidemiology
- Health Policy
- Gretl
- Data Analysis
- Data Management
- Heor
- Quantitative Research
- Sas Programming
- Clinical Trials
- Sql
- Health Services Research
- Clinical Pharmacy
- Statistical Programming
- Health Outcomes
- Microsoft Office
- Healthcare
- Health Economics
- Spss
- Literature Reviews
- Pharmacists
- Pharmacy
- Research Design
- Meta-Analysis
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.